ESAB vs MSA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ESAB exhibits strong operational health with a Piotroski F-Score of 7/9 and a healthy balance sheet (Debt/Equity 0.61), yet it faces a significant valuation disconnect. While the company has a remarkable track record of beating earnings estimates for 16 consecutive quarters, the current price of $101.28 trades at a substantial premium to its Graham Number ($57.36) and Intrinsic Value ($28.70). The outlook is conflicted: analysts maintain a 'strong_buy' with a target of $136.56, but technical trends are bearish (0/100) and YoY earnings growth has plummeted by 31.6%.
MSA exhibits a stable deterministic health profile with a Piotroski F-Score of 4/9 and exceptional liquidity (Current Ratio 3.01), yet it faces a severe valuation disconnect. The stock trades at a significant premium to its Graham Number ($74.76) and Intrinsic Value ($49.63), suggesting the market is pricing in a high-quality moat that current growth rates (Revenue Growth 2.20%) do not fully justify. While profitability metrics (ROE 22.22%) and a consistent track record of earnings beats are strong, the combination of bearish technicals, insider selling, and stagnant YoY earnings growth warrants a neutral stance.
Compare Another Pair
Related Comparisons
ESAB vs MSA: Head-to-Head Comparison
This page compares ESAB Corporation (ESAB) and MSA Safety Incorporated (MSA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.